the aid library

Capacity
Building
Clinical
Guidelines
Key
Resources
Pharmacy &
Technologies
Public
Health
Women & Child
Health
COUNTRIES
TOOLBOXES
- Conflict
- Zika
- TB
- Cholera
- HIV
- Polio
- Rapid Response
- Refugee
- Disability
- Specific Hazards
- Social Ethics
- Health Financing Toolbox

Middle East and North Africa
West and Central Africa
East and Southern Africa
South–East Asia Region
Western Pacific Region
Eastern Europe and Central Asia
Latin America and the Carribbean
Western and Central Europe
North America

Login
Register
English

Search database

Suggest new resources

Filter

Text search: pharmacovigilance policy handbook

Featured

Recommendations

New Publications

Language

English

Russian

Spanish

French

Arabic

Chinese

Document type

No document type

Guidelines

Manuals

Studies & Reports

Training Material

Strategic & Response Plan

Countries / Regions

Eastern Europe

India

Russia

Western and Central Europe

Global

Liberia

Nigeria

Ghana

Uganda

Zimbabwe

Zambia

Kenya

Tanzania

Ukraine

Latin America and the Carribbean

Georgia

Authors & Publishers

World Health Organization WHO

World Health Organisation (WHO)

International Pharmaceutical Federation

WHO

Wiedenmayer, K. et al.

A. Montresor

A. Piubello

CCM Georgia

Central TB Divison, Ministry of Health and Social Welfare, Government of India

Christina Brandes-Barbier, Véronique Millot, Tomas Allen et al

et al.

Federal Ministry of Health, Nigeria

Government of India, Central Tuberculosis Division, Ministry of Health and Family Welfare

International Pharmaceutical Federation (FIP)

Kwonjune J. Seung, Michael L. Rich, Amy Elizabeth Barrera-Cancedda et al.

Medicines Control Authority of Zimbabwe (MCAZ) | Ministry of Health and Child Care

Ministry of Health & Family Welfare, India

Ministry of Health, Kenya

Ministry of Health, Republic of Uganda

MSH, USAID

Organización Mundial de la Salud (OMS), Federación Internacional Farmacéutica (FIP)

Organización Mundial de la Salud OMS

Pan American Health Organisation PAHO

Republic of Libera, Ministry for Health and Social Welfare

Rochweg, B.

Systems for Improved Access to Pharmaceuticals and Services (SIAPS)

Tanzania Food & Drugs Authority (TFDA)

The International Union Against Tuberculosis and Lung Disease

USAID

USAID, TBCARE I, TBCARE II

World Health Organization

World Health Organization (WHO)

World Health Organization (WHO), International Pharmaceutical Federation (FIP)

World Health Organization Europe

World Health Organization WHO, Stop TB

World Health Organization, Europe

World Health Organization, Regional Office for South-East Asia

World Health Organization, Western Pacific

Zambia Medicines Regulatory Authority (ZAMRA)

Всемирная организация здравоохранения

Publication Years

2020-2026

2010-2019

2000-2009

A living WHO guideline on drugs for covid-19
recommended

Rochweg, B.; et al. (2021) CC

BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379 Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE ... COVERY and REMAP-CAP randomised controlled trials triggered this guideline update, resulting in a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19. Prior recommendations: (a) A recommendation not to use ivermectin in patients with covid-19, regardless of disease severity, except in the context of a clinical trial; (b) a strong recommendation against the use of hydroxychloroquine in patients with covid-19, regardless of disease severity; (c) a strong recommendation against the use of lopinavir-ritonavir in patients with covid-19, regardless of disease severity; (d) a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19; (e) a conditional recommendation against systemic corticosteroids in patients with non-severe covid-19; and (f) a conditional recommendation against remdesivir in hospitalised patients with covid-19. more

Download

View PDF

Add to my MEDBOX

Field Guide for the Management of Drug-Resistant Tuberculosis
recommended

A. Piubello The International Union Against Tuberculosis and Lung Disease (2018)

A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.

Download

View PDF

Add to my MEDBOX

Руководство по лечению туберкулеза с множественной лекарственной устойчивостью

Kwonjune J. Seung, Michael L. Rich, Amy Elizabeth Barrera-Cancedda et al. USAID, TBCARE I, TBCARE II (2013) C2

Это руководство предназначено для использования в качестве пособия дл яврачей и других медицинских работников, осуществляющих лечение и уход за больными лекарст� ... �енно-устойчивым туберкулезом. more